What is the best approach to manage a gastric adenoma at a specific gastric location?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Management of Gastric Adenoma

All gastric adenomas should be resected endoscopically, with the technique determined by lesion size: EMR for lesions ≤10 mm and ESD for lesions >10 mm to ensure en bloc resection. 1

Endoscopic Resection Strategy

The British Society of Gastroenterology provides clear, evidence-based guidance on gastric adenoma management that prioritizes complete resection to prevent progression to adenocarcinoma while minimizing morbidity compared to surgical approaches.

Technique Selection Based on Size

  • Lesions ≤10 mm: EMR can achieve en bloc excision
  • Lesions >10 mm: ESD is required to ensure en bloc excision 1

This size-based algorithm is critical because en bloc resection allows proper histopathological assessment and reduces recurrence risk. Recent data confirms that for lesions ≤15 mm, while EMR after circumferential precutting (EMR-P) offers shorter procedure times (8.8 vs 28.9 minutes), ESD provides superior histological complete resection rates (87% vs 57%) 2. For high-grade adenomas specifically, ESD remains the preferred approach regardless of size due to the higher complete resection rate.

Location Considerations

While the question asks about location-specific approaches, the evidence demonstrates that gastric location does not fundamentally alter the endoscopic resection strategy—size and histological grade are the primary determinants. However, for technically difficult locations (gastric cardia, prepyloric antrum), specialized techniques may be needed:

  • Standard EMR/ESD remains first-line
  • For recurrent lesions at the prepyloric antrum where endoscopic approaches risk perforation due to submucosal fibrosis, transgastric single-incision laparoscopic resection can be considered 3

Curative Resection Criteria

Complete (R0) endoscopic resection is considered curative for: 1

  1. Low-grade dysplasia (LGD)
  2. High-grade dysplasia (HGD)
  3. Well or moderately differentiated intramucosal adenocarcinoma (any size, non-ulcerated)
  4. Well or moderately differentiated intramucosal adenocarcinoma (<3.0 cm if ulcerated)
  5. Well or moderately differentiated submucosal adenocarcinoma (<3.0 cm, Sm1 invasion <500 μm)
  6. Poorly differentiated intramucosal adenocarcinoma (≤2.0 cm)

These criteria are based on lymph node metastasis (LNM) risk <1%, making endoscopic resection both curative and organ-preserving with significantly lower morbidity/mortality than gastrectomy 1.

Critical Pre-Resection Steps

Before proceeding with resection: 1

  • Discuss the case in a multidisciplinary team (MDT) with pathologists and therapeutic endoscopists
  • Perform careful evaluation of the entire stomach to identify synchronous neoplasia (present in up to 30% of cases) 1
  • Assess for background gastric atrophy and intestinal metaplasia
  • If local expertise is unavailable, refer to an expert center
  • Discuss risks/benefits of endoscopic resection versus surgery with the patient

High-Risk Features Requiring Surgery

Proceed to surgical resection if histopathology reveals: 1

  1. Poorly differentiated submucosal cancer (any invasion depth)
  2. Signet ring cell carcinoma
  3. Lymphovascular invasion
  4. Submucosal invasion ≥500 μm from muscularis mucosae

These features confer significantly higher LNM risk (up to 22.7% in high-risk groups) 1, making endoscopic resection inadequate.

Post-Resection Surveillance

Surveillance endoscopy schedule: 1

  • First follow-up: 6 months post-resection
  • Subsequent surveillance: Annually if no lesions identified

This intensive surveillance is justified by the 10-20% risk of synchronous, metachronous, or recurrent lesions, with most recurrences occurring within the first year 1.

Common Pitfalls to Avoid

  1. Attempting EMR for lesions >10 mm: This compromises en bloc resection and increases recurrence risk
  2. Missing synchronous lesions: Always perform complete gastric examination before and after resection
  3. Inadequate histological assessment: Piecemeal resection prevents accurate staging
  4. Proceeding without MDT discussion: Complex cases benefit from multidisciplinary expertise
  5. Ignoring high-risk histological features: These mandate surgical referral, not continued endoscopic management

The evidence strongly supports endoscopic resection as the preferred organ-preserving treatment that balances cancer prevention with quality of life, avoiding the significant morbidity and mortality of gastrectomy for appropriately selected lesions.

References

Related Questions

For a gastric adenoma with low-grade dysplasia under endoscopic surveillance, how often should repeat gastroscopy be performed?
What are the guidelines for managing a single prepyloric polyp identified on esophagogastroduodenoscopy (EGD)?
How should gastric adenopathy be evaluated and managed?
What is the appropriate follow‑up surveillance plan for a 70‑year‑old man who underwent piecemeal cold‑snare resection of an 8 mm duodenal tubular adenoma with low‑grade dysplasia, has normal distal esophageal biopsies without intestinal metaplasia or dysplasia, and is currently taking pantoprazole?
Is it safe to use mirtazapine (Remeron) as a sleep aid in a patient with blood pressure 162/95 mm Hg?
Is it safe to start Trintillex (vortioxetine) 10 mg daily together with Wellbutrin (bupropion) 150 mg daily?
A patient taking bupropion (Wellbutrin) 300 mg daily and sertraline 50 mg daily reports insomnia and decreased libido; how should these side effects be managed?
In a 32-year-old woman at 40 weeks gestation presenting with sore throat, wet cough, rhinorrhea, no fever, normal lung examination, and mildly elevated C-reactive protein, what treatment is appropriate?
What organisms commonly cause pelvic inflammatory disease in India?
What is the recommended management for an obstructive gastric lesion causing persistent nausea, vomiting, early satiety, or inability to tolerate oral intake?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.